Stocks / NASDAQ / Juniper Pharmaceuticals, Inc.

Juniper Pharmaceuticals, Inc.

Our Opinion

Juniper Pharmaceuticals, Inc. is on the Cruelty Free Investing use of animals list because they use animals for drug testing and clinical trials.

Supporting Evidence:

The company stated in the following press release that they conduct pre-clinical trials of their drugs on animals.

“Juniper’s IVR programs are led by JNP-0101, an investigational oxybutynin IVR for the treatment of overactive bladder (OAB) in women. ¬†Roughly nine million women receive pharmacotherapy for this chronic condition in the United States alone. IND-enabling animal PK studies are underway, and the Company expects pilot study results later this year.” Read the following article

Company Description

Juniper Pharmaceuticals, Inc., formerly Columbia Laboratories, Inc., is a pharmaceutical company that engages in the development of therapeutics that addresses unmet medical needs in women’s health. Its pipeline development is funded by cash flows from its CRINONE franchise and services business. It is currently developing COL-1077, a 10% lidocaine bioadhesive gel intended as an acute use anesthetic for minimally invasive gynecological procedures. The company was founded in December 1986 and is headquartered in Boston, MA. [Source: MarketWatch]

Company Website: http://www.juniperpharma.com